AJP - Endocrinology and Metabolism, Vol 266, Issue 3 E438-E447, Copyright © 1994 by American Physiological Society

ARTICLES

Role of glucagon in the metabolic response to stress hormone infusion in the conscious dog

O. P. McGuinness, K. Burgin, C. Moran, D. Bracy and A. D. Cherrington
Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee 37232-0615.

The impact of the absence of an increase in glucagon on the metabolic response to stress hormone infusion was investigated. We studied 11 conscious dogs fasted for 20 h before (day 0) and after (day 3) a 70-h stress hormone infusion containing glucagon, cortisol, epinephrine, and norepinephrine that increased their respective levels approximately sixfold. Five additional dogs were studied on day 0 and were then infused with the same stress hormone infusion but without glucagon. Glucose production and gluconeogenesis were assessed using tracer and arteriovenous difference techniques. The absence of an increase in glucagon during stress hormone infusion attenuated the increase in arterial plasma glucose concentration (delta 81 +/- 16 vs. delta 28 +/- 6 mg/dl) but did not significantly alter the increase in the rate of glucose appearance (delta 1.7 +/- 0.3 vs. delta 1.1 +/- 0.4 mg.kg-1.min-1). However, it eliminated the increase in net hepatic glucose output (delta 0.7 +/- 0.3 vs. delta 0.0 +/- 0.4 mg.kg-1.min-1) primarily because of an increase in hepatic glucose uptake. In addition, the stress hormone-induced increase in net hepatic gluconeogenic precursor uptake (delta 0.7 +/- 0.3 vs. delta 0.2 +/- 0.1 mg of glucose.kg-1.min-1) and the efficiency of gluconeogenesis (delta 0.19 +/- 0.07 vs. delta 0.01 +/- 0.05) were attenuated. Glucagon thus plays a pivotal role in the metabolic response to stress hormone infusion by sustaining gluconeogenesis through a stimulatory effect on the hepatic gluconeogenic precursor uptake as well as on the efficiency of gluconeogenesis within the liver.

This article has been cited by other articles:

				S.-S. Chen, Y. Zhang, T. S. Santomango, P. E. Williams, D. B. Lacy, and O. P. McGuinness Glucagon chronically impairs hepatic and muscle glucose disposal Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E928 - E935. [Abstract] [Full Text] [PDF]

				C. Everett-Grueter, D. S. Edgerton, E. P. Donahue, S. Vaughan, C. A. Chu, D. K. Sindelar, and A. D. Cherrington The effect of an acute elevation of NEFA concentrations on glucagon-stimulated hepatic glucose output Am J Physiol Endocrinol Metab, September 1, 2006; 291(3): E449 - E459. [Abstract] [Full Text] [PDF]

				S.-S. Chen, C. M. Donmoyer, D. A. Pearson, A. Poole, Y. Zhang, D. B. Lacy, and O. P. McGuinness Impact of infection on glucose-dependent liver glucose uptake during TPN: interaction with insulin Am J Physiol Endocrinol Metab, February 1, 2004; 286(2): E286 - E295. [Abstract] [Full Text] [PDF]

				S. M. Gustavson, C. A. Chu, M. Nishizawa, B. Farmer, D. Neal, Y. Yang, S. Vaughan, E. P. Donahue, P. Flakoll, and A. D. Cherrington Glucagon's actions are modified by the combination of epinephrine and gluconeogenic precursor infusion Am J Physiol Endocrinol Metab, September 1, 2003; 285(3): E534 - E544. [Abstract] [Full Text] [PDF]

				S. M. Gustavson, C. A. Chu, M. Nishizawa, B. Farmer, D. Neal, Y. Yang, E. P. Donahue, P. Flakoll, and A. D. Cherrington Interaction of glucagon and epinephrine in the control of hepatic glucose production in the conscious dog Am J Physiol Endocrinol Metab, April 1, 2003; 284(4): E695 - E707. [Abstract] [Full Text] [PDF]

				C. M. Donmoyer, S.-S. Chen, D. B. Lacy, D. A. Pearson, A. Poole, Y. Zhang, and O. P. McGuinness Infection impairs insulin-dependent hepatic glucose uptake during total parenteral nutrition Am J Physiol Endocrinol Metab, March 1, 2003; 284(3): E574 - E582. [Abstract] [Full Text] [PDF]

				C. M. Donmoyer, J. Ejiofor, D. B. Lacy, S.-S. Chen, and O. P. McGuinness Fructose augments infection-impaired net hepatic glucose uptake during TPN administration Am J Physiol Endocrinol Metab, May 1, 2001; 280(5): E703 - E711. [Abstract] [Full Text] [PDF]

				O. P. McGuinness, J. Ejiofor, D. B. Lacy, and N. Schrom Hepatic glucose metabolism during intraduodenal glucose infusion: impact of infection Am J Physiol Endocrinol Metab, July 1, 2000; 279(1): E108 - E115. [Abstract] [Full Text] [PDF]

				O. P. McGuinness, V. Shau, E. M. Benson, M. Lewis, R. T. Snowden, J. E. Greene, D. W. Neal, and A. D. Cherrington Role of epinephrine and norepinephrine in the metabolic response to stress hormone infusion in the conscious dog Am J Physiol Endocrinol Metab, October 1, 1997; 273(4): E674 - E681. [Abstract] [Full Text] [PDF]

				I. Bady, C. Zitoun, L. Guignot, and G. Mithieux Activation of liver G-6-Pase in response to insulin-induced hypoglycemia or epinephrine infusion in the rat Am J Physiol Endocrinol Metab, April 1, 2002; 282(4): E905 - E910. [Abstract] [Full Text] [PDF]